Results

Total Results: 514 records

Showing results for "blood pressure medications".

101. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
     December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…

102. Politi (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
     December 26, 2012 - discussing BP  medication About 2 out of 100 patients who take this medication will develop low blood … pressure. … What not to do: 2 out of 10 patients who  take this medication  could  develop low blood  pressure

103. Field Triage Guideline Revision: Glasgow Coma Scale: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/field-triage-glascow/research-protocol
     February 28, 2016 - pressure, level of intoxication, type of trauma, or intubation or receipt of medications in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field

104. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/field-triage-glascow_research-protocol.pdf
     February 25, 2016 - pressure, level of intoxication, type of trauma, or intubation or receipt of medications in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … pressure, level of intoxication, type of trauma, or intubation or receipt of medication in the field … unspecified or other trauma, systolic blood pressure, level of intoxication, type of trauma, or intubation

105. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - pressure outcomes. … [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, tx, kw, ct, sh, bt, id, cc] 48. exp blood pressure/ 49. blood … : ≥1 year follow-up o Intermediate outcomes (blood pressure and lipids): ≥1 month follow-up … pressure). … For BLOOD PRESSURE, was BP measured at baseline and was there a follow- up clinical encounter (where

106. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
     April 22, 2013 - Peer Reviewer 7 Methods, Table 2 On page 32, blood pressure is listed as an intermediate outcome, but … Blood pressure was not intended as a separate outcome and has been deleted from the analytic framework … Blood pressure outcomes, when reported with other CVD risk factors, were an intended outcome for KQ … 4, and the results have been updated with the blood pressure results. … pressure together with smoking cessation.

107. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - coronary artery to measure a pressure gradient across a blockage during administration of vasodilating medications … pressure and diabetes; counseling related to diet, physical activity, smoking cessation, alcohol … renal failure, allergy, nephrogenic systemic fibrosis, contrast- related harms, adverse reaction to medications … BP = blood pressure; CABG = coronary artery bypass graft; CAD = coronary artery disease; DM = diabetes … Blood pressure and breathing are monitored as well. 22 Archived: This report is greater than 3 years

108. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
     December 14, 2010 - outcomes: o Short-term: - fasting glucose level - hemoglobin A1c (HbA1c) - triglycerides - blood … pressure o Long-term: - % with sleep apnea - % with GERD - % with diabetes resolution/improvement … - % off anti-diabetic medications - % being euglycemic - time to diabetes resolution - weight loss … Short-term benefits  Fasting glucose level  Hemoglobin A1c (HbA1c)  Triglycerides  Blood … pressure resolution/ improvement Harms:  Adverse effects: mortality  Reoperation after

109. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Garlic plus warfarin versus warfarin alone on post-treatment lipid profile, blood pressure, INR, platelet … pressure were not significant (results for lipids and blood pressure inconclusive; grade: insufficient … pressure, and bleeding time. … Garlic plus warfarin versus warfarin alone on post-treatment lipid profile, blood pressure, INR, platelet … pressure were not significant (results for lipids and blood pressure inconclusive; grade: insufficient

110. Wireless-Motility-Capsule Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
     May 01, 2013 - Medications that commonly cause gastric emptying delay are opiates or glucagon-like peptide agonists … Other outcomes include the ability of testing to influence treatment decisions (e.g., changes in medications … Medical management includes avoiding constipating medications and initiating bulking agents (e.g., … There were no language Treatment Decisions • Change in medications • Change in nutrition • Surgery … We had included patient outcomes (need for medications, additional tests) as outcomes in our review

111. Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/sleep-apnea/research-protocol
     March 15, 2010 - arrhythmia events, coronary artery disease events, hypertension (diagnosis, resolution, or reduction in medications … measures Apnea hypopnea index Number of arousals Time in deeper sleep stages Hemoglobin A1c Blood … pressure Adherence / Compliance Categorical (adhering or not adhering) Time (hours) using device … that not within the original sleep study; must be from a subsequent evaluation Hemoglobin A1c and blood … pressure: 4 weeks Compliance: 4 weeks (KQ 6 & 7: no minimum duration) Adverse events: No minimum

112. Comparative Effectiveness of Treatment for Open-Angle Glaucoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/glaucoma-treatment/research-protocol
     November 16, 2010 - description of Food and Drug Administration (FDA) approval status, indications, and warnings for each of the medications … addition, we will review the Scientific Information Packets provided by the manufacturers of the glaucoma medications … outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications

113. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - of Food and Drug Administration (FDA) approval status, indications, and warnings for each of the medications … , we will review the Scientific Information Packets provided by the manufacturers of the glaucoma medications … outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications

114. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
     May 19, 2020 - Pharmacologic Treatment Pharmacologic treatments for breathlessness in advanced cancer may include medications … outcomes (KQ1-4) • Respiratory rate • Oxygen or carbon dioxide/ bicarbonate levels • Heart rate • Blood … pressure • Objective measure of exercise capacity, e.g., 6-minute walk test • Level of sedation • … outcomes (KQ 1-4) • Respiratory rate • Oxygen or carbon dioxide/ bicarbonate levels • Heart rate • Blood … pressure • Objective measure of exercise capacity • Level of sedation • Utilization outcomes linked

115. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
     March 14, 2012 - Delay of gastric emptying is commonly caused by the use of certain medications such as narcotics or … Most radiology centers require that all possible interfering medications such as narcotics, motility … Other outcomes include the ability of testing to influence treatment decisions by changes in medications … Change in medications 2. Change in nutrition 3. … scintigraphy, antroduodenal manometry, or endoscopy Treatment Decisions • Change in medications

116. Tonsillectomy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
     February 10, 2016 - The  role  of   perioperative  anti-­inflammatory  medications  (e.g.,  non-­steroidal  anti-­inflammatory … Postoperative  medications  may  reduce  nausea  and  vomiting,   postoperative  swelling,  and  operative … Some   comments  suggested  that  we  needed  to  clarify  comparator  medications  or  specify  additional … The  evidence  base  includes  many   different  medications,  and  combinations   of  medications,   … Anti-­inflammatory  medications:  Over-­the-­counter  non-­steroidal  anti-­inflammatory  medications

117. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - Food and Drug Administration for hypertension, so it obviously reduces blood pressure more than placebo … Food and Drug Administration for hypertension, it obviously reduces blood pressure more than placebo … Questions That Reflect Uncertainty (I) Does aliskerin reduce blood pressure in hypertensive patients … The first question is, “Does aliskerin reduce blood pressure in hypertensive patients more than other … Because thiazide diuretics already reduce blood pressure and reduce final health outcomes, the impact

118. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/wireless-motility-capsule/research-protocol
     March 14, 2012 - Delay of gastric emptying is commonly caused by the use of certain medications such as narcotics or glucagon-like … Most radiology centers require that all possible interfering medications such as narcotics, motility … Other outcomes include the ability of testing to influence treatment decisions by changes in medications … Other outcomes include the ability of testing to influence treatment decisions such as change in medications … Motility assessment Transit time Pressure patterns Treatment decisions Change in medications

119. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - pressure, glycemia), combination versus monotherapy, and intensive multidisciplinary interventions … (simultaneous targeting of blood pressure, diabetes, cholesterol, and/or reducing nephrotoxic drug … These AE’s are for use of these medications in general, not specific to use in CKD. … pressure: randomised controlled trial. … (simultaneous targeting of blood pressure, diabetes, cholesterol, and/or reducing nephrotoxic drug

120. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - reduced while controlling carbohydrate intake) and then, if needed, one or more oral hypoglycemic medications … pressure, and cholesterol levels.15-18 The responsibility for this extensive, multicomponent disease … management program (e.g., consisting of one or more interventions actively adjusting diabetes-related medications … Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes … increase adherence to medication for hyperglycemia or risk factor reduction (e.g., lipid-lowering medications